Literature Search

Alam(A),Li(Y),Ning(F),Li(T),Wang(Y) ACS Appl Mater Interfaces 2025-03-19

...Vim. CsPbBr3-GPA@PDVB-Vim retains over 76% of its initial photoluminescence intensity after 31 days in water and 68% aft...

Xu(SS),Akram(H),Lind(V),Hyam(J),Davagnanam(I… BMJ Neurol Open 2025-00-00

...Vim) is an effective therapy for medication-refractory essential tremor (ET). The Vim is not readily visualised on conve...

Matheus(TC),Menezes(WM),Rigo(OD),Kabayama(LK… Int Endod J 2011-06-00

...VIM) processed NiTi ingots were tested, Ti-49.81 at%Ni and Ti-50.33 at%Ni, named VIM 1 and VIM 2. A brief analysis relat...

Herre(C),Nshdejan(A),Klopfleisch(R),Corte(GM… PLoS One 2022-00-00

...vimentin (VIM), triosephosphate isomerase (TPI) and adenosylmethionine synthetase isoform type-2 (MAT2A) during the whol...

Kim(Hye Jin),Kim(Hyung Sun),Lee(Jae Myun),Yo… Ann Lab Med 0000-00-00

...VIM-2). These results indicate that the acquisition of bla(VIM-2) or bla(IMP-1) may not play a major role in carbapenem ...

Herre(C),Nshdejan(A),Klopfleisch(R),Corte(GM… PLoS One 2023-00-00

...vimentin (VIM) and adenosylmethionine synthetase isoform type 2 (MAT2A) expression. Furthermore, native expression profi...

Rodrigues-Junior(DM),Ali(MM),Itoh(Y),Ferreir… Nucleic Acids Res 2026-01-14

...VIM-AS1 (Vimentin antisense RNA1) variant-2 (v.2) via a transcriptional SMAD-GATA6-SPI1 complex. VIM-AS1 v.1 and v.2 loc...

Xiao(J),Chen(L),Melander(O),Orho-Melander(M)… Stroke 2021-00-00

VIM (vimentin) is a cytoskeletal intermediate filament protein, which has been linked to atherosclerosis and thrombosis;...

Catho(G),Martischang(R),Boroli(F),Chraïti(MN… Crit Care 2021-00-19

...VIM carbapenemase (PA-VIM) in the adult intensive care unit (ICU) of a Swiss tertiary care hospital with active case fin...

Petrova(A),Ivanov(IN),Paunov(L),Uchikov(A),S… Folia Med (Plovdiv) 2024-12-31

...VIM-2-producing representative of Pseudomonasputida group - Pseudomonaskurunegalensis from the largest Bulgarian hospita...